M&A Deal Summary

Tergus Pharma Acquires EnDev Laboratories

On March 22, 2018, Tergus Pharma acquired life science company EnDev Laboratories

Acquisition Highlights
  • This is Tergus Pharma’s 1st transaction in the Life Science sector.
  • This is Tergus Pharma’s 1st transaction in the United States.
  • This is Tergus Pharma’s 1st transaction in North Carolina.

M&A Deal Summary

Date 2018-03-22
Target EnDev Laboratories
Sector Life Science
Buyer(s) Tergus Pharma
Deal Type Add-on Acquisition

Target

EnDev Laboratories

Kannapolis, North Carolina, United States
EnDev Laboratories is a provider of a dermatological R&D, and significant skin biology research capability that includes skin irritation, skin sensitization, and drug activity testing using healthy or genetically-modified In Vitro and/or in Ex Vivo human skin models.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tergus Pharma

Durham, North Carolina, United States

Category Company
Founded 1995
Sector Life Science
DESCRIPTION

Tergus Pharma is an end-to-end service provider for topical pharmaceutical research, drug development, testing, and manufacturing companies. The company delivers quality results to clients from formulation through manufacturing, which is why people say, “Think Topicals, Think Tergus.” A systematic and scientific approach is used to thoroughly understand product components, processing, and finished product attributes to ensure high-quality products throughout the course of development. It helps clients achieve a balance between a fast-tracked program and quality science. Tergus Pharma was founded in 1995 and is based in Durham, North Carolina.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: North Carolina M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1